How does 35 U.S.C. 121 relate to restriction requirements in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. 35 U.S.C. 121 is the statutory foundation for restriction requirements in patent applications. It…
Read MoreWhat is the difference between the 1996 and 2007 USPTO policies on nucleotide sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The 1996 and 2007 USPTO policies on nucleotide sequences differ…
Read MoreWhat is the 18-month publication rule for patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The 18-month publication rule, as specified in 35 U.S.C. 122(b),…
Read MoreWhat are the limitations of 37 CFR 1.131(a) affidavits in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. While 37 CFR 1.131(a) affidavits are useful for antedating certain…
Read MoreWhat role does licensing play in demonstrating commercial success for patents?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Licensing can play a significant role in demonstrating commercial success…
Read MoreWhat are ‘Large Tables’ in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. ‘Large Tables’ in patent applications are defined in 37 CFR…
Read MoreWhat happens if there’s a lack of objective evidence of nonobviousness in a patent application?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The absence of objective evidence of nonobviousness in a patent…
Read MoreWhat are the key components of the utility requirement in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The utility requirement is a fundamental aspect of patent law,…
Read MoreHow do ‘intermediate range’ cases affect unexpected results arguments in patents?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. ‘Intermediate range’ cases present unique challenges when arguing for unexpected…
Read MoreHow is diligence evaluated in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Diligence in patent applications is evaluated on a case-by-case basis,…
Read More